Pediatric drug surveillance and the food and drug administration's adverse event reporting system: An overview of reports, 2003-2007

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 1, 2009, Pages 24-27

  Johann Liang, Rosemary ^a   Wyeth, Jo ^b   Chen, Min ^b   Cope, Judith U ^b  

^a HEALTH RESOURCES AND SERVICES ADMINISTRATION   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Adverse events; Children; Drug safety; Drug surveillance; Pediatric; Reporting

Indexed keywords

ANTI ACNE AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; CONTRACEPTIVE AGENT; CYCLOOXYGENASE 2 INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOMODULATING AGENT; INTERFERON; MONOCLONAL ANTIBODY; NEUROLEPTIC AGENT; OPIATE; RESPIRATORY TRACT AGENT; DERMATOLOGICAL AGENT; DRUG;

ADVERSE OUTCOME; AGE DISTRIBUTION; BEST PHARMACEUTICALS FOR CHILDREN ACT; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; FOOD AND DRUG ADMINISTRATION; HUMAN; LAW; PEDIATRICS; PRIORITY JOURNAL; REVIEW; SCREAMING SYNDROME; ACNE VULGARIS; ADOLESCENT; ADULT; AGE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; HOSPITALIZATION; INFANT; MIDDLE AGED; PRESCHOOL CHILD; RESPIRATORY TRACT DISEASE; STATISTICS; UNITED STATES;

ACNE VULGARIS; ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE FACTORS; ANTICONVULSANTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; DERMATOLOGIC AGENTS; HUMANS; INFANT; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; RESPIRATORY TRACT DISEASES; SEVERITY OF ILLNESS INDEX; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; YOUNG ADULT;

EID: 59049100725     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1679     Document Type: Review

References (14)

1. Ahmad SR, Goetsch RA, Marks NS. Spontaneous reporting in the United States. In Pharmacoepidemiology, 4th ed. Strom BL (ed.). John Wiley and Sons, Ltd: Chichester, UK, 2005; 135-159.
2. Bonnel RA, Graham DJ. Peripheral neuropathy in patients treated with leflunomide. Clin Pharmacol Ther 2004; 75(6): 580-585.
3. Best Pharmaceuticals for Children Act. Pub.L. No. 107-109 (Jan 4, 2002) http://www.fda.gov/opacom/laws/pharmkids/contents.html (accessed 8 May 2007).
4. FDA. Pediatric Advisory Committee meetings. FDA Office of Pediatric Therapeutics, Rockville; 2006. http://www.fda.gov/oc/opt/ PACmeetings.html (accessed 8 May 2007).
5. Postmarketing reporting of adverse drug experiences. 21 C.F.R. Sect. 314.80 (2006). http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/ CFRSearch.cfm?fr=314.80 (accessed 9 May 2007).
6. Vector One®: National [electronic database]. Yardley (PA): Verispan, LLC. Years 2002-2007, Extracted March 2008.
7. U.S. Census Bureau. Annual Estimates of the Population by Selected Age Groups and Sex for the United States (2006). http://www.census.-gov/ popest/archives/ (accessed January 31, 2008).
8. Smith PB, Benjamin DK, Murphy MD, Johann-Liang R, et al. Safety monitoring of drugs receiving pediatric marketing exclusivity. Pediatrics 2008; 122: e628-d633.
9. Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. Arch Intern Med 2007; 167(16): 1752-1759.
10. Shah SS, Hall M, Goodman DM, Feuer P, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med 2007; 161(3): 282-290.
11. Worthy KC, Governale LA. Trends in outpatient prescription drug usage in the US 2002-2005 [abstract]. 12th Annual FDA Science Forum 2006; I-13. http://www.accessdata.fda.gov/scripts/oc/scienceforum/sf2006/ search/preview.cfm?keyword=worthy&abstract_id=642&type= coauthor&backto=search (accessed 8 May 2007).
12. Miller MA. Gender-based differences in the toxicity of pharmaceuticals - the Food and Drug Administration's perspective. Int J Toxicol 2001; 20(3): 149-152.
13. Ouellet-Hellstrom R, Kornegay C, Johann-Liang R. Gender-differential drug risk evaluation in adolescents and young adults: examination of top 30 drug prescriptions data. 12th Annual FDA Science Forum 2006; I-PO-28. http://www.accessdata.fda.gov/scripts/oc/scienceforum/sf2006/ search/preview.cfm?keyword=johann&abstract_id= 1016&type=coauthor&backto=search (accessed 8 May 2007).
14. Gardner S, Flack M. Designing a Medical Device Surveillance Network: Report to Congress. FDA Center for Devices and Radiologic Health, Rockville; Sep 1999. http://www.fda.gov/cdrh/postsurv/medsun.html (accessed 8 May 2007).